Stem/Progenitor Cells and Their Therapeutic Application in Cardiovascular Disease

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2018 Nov 9

PMID 30406100

Citations 11

Authors

Yuning Hou

Chunying Li

Affiliations

Soon will be listed here.

Abstract

Cardiovascular disease is the leading cause of death in the world. The stem/progenitor cell-based therapy has emerged as a promising approach for the treatment of a variety of cardiovascular diseases including myocardial infarction, stroke, peripheral arterial disease, and diabetes. An increasing number of evidence has shown that stem/progenitor cell transplantation could replenish damaged cells, improve cardiac and vascular functions, and repair injured tissues in many pre-clinical studies and clinical trials. In this review, we have outlined the major types of stem/progenitor cells, and summarized the studies in applying these cells, especially endothelial stem/progenitor cells and their derivatives, in the treatment of cardiovascular disease. Here the strategies used to improve the stem/progenitor cell-based therapies in cardiovascular disease and the challenges with these therapies in clinical applications are also reviewed.

Citing Articles

Pretreatment with Notoginsenoside R1 enhances the efficacy of neonatal rat mesenchymal stem cell transplantation in model of myocardial infarction through regulating PI3K/Akt/FoxO1 signaling pathways.

Cai H, Han X, Luo Z, Wang Q, Lu P, Mou F Stem Cell Res Ther. 2024; 15(1):419.

PMID: 39533348 PMC: 11558819. DOI: 10.1186/s13287-024-04039-x.

Identification of differentially expressed mRNAs as novel predictive biomarkers for gastric cancer diagnosis and prognosis.

Zhou J, Zhang Y, Huang Z, Yuan Y, Jin J World J Gastrointest Oncol. 2024; 16(5):1947-1964.

PMID: 38764850 PMC: 11099425. DOI: 10.4251/wjgo.v16.i5.1947.

Astragaloside IV induces endothelial progenitor cell angiogenesis in deep venous thrombosis through inactivation of PI3K/AKT signaling.

Lyu X, Yi Z, He Y, Zhang C, Zhu P, Liu C Histol Histopathol. 2024; 39(9):1149-1157.

PMID: 38275076 DOI: 10.14670/HH-18-704.

Upregulated miR-206 Aggravates Deep Vein Thrombosis by Regulating GJA1-Mediated Autophagy of Endothelial Progenitor Cells.

Li Y, Ge J, Yin Y, Yang R, Kong J, Gu J Cardiovasc Ther. 2022; 2022:9966306.

PMID: 35360546 PMC: 8956392. DOI: 10.1155/2022/9966306.

Chronic Obstructive Pulmonary Disease and the Cardiovascular System: Vascular Repair and Regeneration as a Therapeutic Target.

Karnati S, Seimetz M, Kleefeldt F, Sonawane A, Madhusudhan T, Bachhuka A Front Cardiovasc Med. 2021; 8:649512.

PMID: 33912600 PMC: 8072123. DOI: 10.3389/fcvm.2021.649512.

References

Pirro M, Stingeni L, Vaudo G, Mannarino M, Ministrini S, Vonella M . Systemic inflammation and imbalance between endothelial injury and repair in patients with psoriasis are associated with preclinical atherosclerosis. Eur J Prev Cardiol. 2014; 22(8):1027-35. DOI: 10.1177/2047487314538858. View

Guo Y, Ledesma R, Peng R, Liu Q, Xu D . The Beneficial Effects of Cardiac Rehabilitation on the Function and Levels of Endothelial Progenitor Cells. Heart Lung Circ. 2016; 26(1):10-17. DOI: 10.1016/j.hlc.2016.06.1210. View

Donndorf P, Kaminski A, Tiedemann G, Kundt G, Steinhoff G . Validating intramyocardial bone marrow stem cell therapy in combination with coronary artery bypass grafting, the PERFECT Phase III randomized multicenter trial: study protocol for a randomized controlled trial. Trials. 2012; 13:99. PMC: 3419083. DOI: 10.1186/1745-6215-13-99. View

Blocklet D, Toungouz M, Berkenboom G, Lambermont M, Unger P, Preumont N . Myocardial homing of nonmobilized peripheral-blood CD34+ cells after intracoronary injection. Stem Cells. 2005; 24(2):333-6. DOI: 10.1634/stemcells.2005-0201. View

Liu Y, Roan J, Wang S, Hwang S, Tsai M, Chen J . Xenografted human amniotic fluid-derived stem cell as a cell source in therapeutic angiogenesis. Int J Cardiol. 2012; 168(1):66-75. DOI: 10.1016/j.ijcard.2012.09.072. View

Zhang X, Su C, Cao Z, Xu S, Xia W, Xie W . CXCR7 upregulation is required for early endothelial progenitor cell-mediated endothelial repair in patients with hypertension. Hypertension. 2013; 63(2):383-9. DOI: 10.1161/HYPERTENSIONAHA.113.02273. View

Hou Y, Wu Y, Farooq S, Guan X, Wang S, Liu Y . A critical role of CXCR2 PDZ-mediated interactions in endothelial progenitor cell homing and angiogenesis. Stem Cell Res. 2015; 14(2):133-43. DOI: 10.1016/j.scr.2014.12.001. View

Leistner D, Fischer-Rasokat U, Honold J, Seeger F, Schachinger V, Lehmann R . Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy. Clin Res Cardiol. 2011; 100(10):925-34. DOI: 10.1007/s00392-011-0327-y. View

Madeddu P, Emanueli C, Pelosi E, Salis M, Cerio A, Bonanno G . Transplantation of low dose CD34+KDR+ cells promotes vascular and muscular regeneration in ischemic limbs. FASEB J. 2004; 18(14):1737-9. DOI: 10.1096/fj.04-2192fje. View

10.

Niiyama H, Huang N, Rollins M, Cooke J . Murine model of hindlimb ischemia. J Vis Exp. 2009; (23). PMC: 2763292. DOI: 10.3791/1035. View

11.

Chien S, Huang C, Tsai C, Wang S, Lin Y, Tang C . Interleukin-1β induces fibroblast growth factor 2 expression and subsequently promotes endothelial progenitor cell angiogenesis in chondrocytes. Clin Sci (Lond). 2016; 130(9):667-81. PMC: 4797417. DOI: 10.1042/CS20150622. View

12.

Miyahara Y, Nagaya N, Kataoka M, Yanagawa B, Tanaka K, Hao H . Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med. 2006; 12(4):459-65. DOI: 10.1038/nm1391. View

13.

Seminatore C, Polentes J, Ellman D, Kozubenko N, Itier V, Tine S . The postischemic environment differentially impacts teratoma or tumor formation after transplantation of human embryonic stem cell-derived neural progenitors. Stroke. 2009; 41(1):153-9. DOI: 10.1161/STROKEAHA.109.563015. View

14.

Cui B, Huang L, Fang Y, Guo R, Yin Y, Zhao X . Transplantation of endothelial progenitor cells overexpressing endothelial nitric oxide synthase enhances inhibition of neointimal hyperplasia and restores endothelium-dependent vasodilatation. Microvasc Res. 2010; 81(1):143-50. DOI: 10.1016/j.mvr.2010.09.009. View

15.

Pirro M, Bocci E, Di Filippo F, Schillaci G, Mannarino M, Bagaglia F . Imbalance between endothelial injury and repair in patients with polymyalgia rheumatica: improvement with corticosteroid treatment. J Intern Med. 2012; 272(2):177-84. DOI: 10.1111/j.1365-2796.2011.02510.x. View

16.

Suuronen E, Veinot J, Wong S, Kapila V, Price J, Griffith M . Tissue-engineered injectable collagen-based matrices for improved cell delivery and vascularization of ischemic tissue using CD133+ progenitors expanded from the peripheral blood. Circulation. 2006; 114(1 Suppl):I138-44. DOI: 10.1161/CIRCULATIONAHA.105.001081. View

17.

Foubert P, Matrone G, Souttou B, Lere-Dean C, Barateau V, Plouet J . Coadministration of endothelial and smooth muscle progenitor cells enhances the efficiency of proangiogenic cell-based therapy. Circ Res. 2008; 103(7):751-60. DOI: 10.1161/CIRCRESAHA.108.175083. View

18.

Maraldi T, Riccio M, Pisciotta A, Zavatti M, Carnevale G, Beretti F . Human amniotic fluid-derived and dental pulp-derived stem cells seeded into collagen scaffold repair critical-size bone defects promoting vascularization. Stem Cell Res Ther. 2013; 4(3):53. PMC: 3706961. DOI: 10.1186/scrt203. View

19.

Frederick J, Fitzpatrick 3rd J, McCormick R, Harris D, Kim A, Muenzer J . Stromal cell-derived factor-1alpha activation of tissue-engineered endothelial progenitor cell matrix enhances ventricular function after myocardial infarction by inducing neovasculogenesis. Circulation. 2010; 122(11 Suppl):S107-17. PMC: 4156010. DOI: 10.1161/CIRCULATIONAHA.109.930404. View

20.

Wollert K, Meyer G, Muller-Ehmsen J, Tschope C, Bonarjee V, Larsen A . Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial. Eur Heart J. 2017; 38(39):2936-2943. DOI: 10.1093/eurheartj/ehx188. View